Peer Supported Web-based CBT for OEF/OIF Veterans With PTSD and Substance Misuse
1 other identifier
interventional
30
1 country
1
Brief Summary
Veterans who served in Iraq and Afghanistan have high rates of co-morbid PTSD symptoms and hazardous substance use (HSU). Evidence-based treatments for these problems are available in VA specialty clinics, but multiple barriers lead to low utilization of these treatments. Novel treatment approaches are needed. Previous research supports that 1) primary care-mental health integration (PC-MHI) services are associated with increased treatment engagement, 2) technology-based interventions are well accepted by Veterans and are more effective when delivered with professional support, and 3) Veteran peer services are associated with improved treatment engagement, patient motivation, and overall functioning. This study will add a Peer-Support component to an existing Web-based Cognitive Behavioral Treatment (CBT) for PTSD and HSU called Moving Forward. Preliminary data analyses from our NIAAA-funded trial indicate that participants who used Moving Forward more had larger reductions in PTSD symptoms. Qualitative feedback supports that Veterans want interpersonal interactions while receiving treatment and need help engaging in the treatment more fully. Therefore, this pilot study will investigate if adding peer support to Moving Forward improves patients outcomes. A randomized controlled trial (N=30) comparing Moving Forward to Peer-Supported Moving Forward will be conducted. The peer support component will consist of semi-structured brief sessions conducted weekly for the 12 weeks of study treatment by a VA-certified peer support specialist. Peers will receive study-specific training and weekly supervision from clinicians that are part of the study staff. Primary outcomes will include process outcomes (treatment engagement, patient satisfaction) and clinical outcomes (PTSD symptoms, alcohol and substance use, quality of life).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 19, 2015
CompletedFirst Posted
Study publicly available on registry
November 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedApril 25, 2017
April 1, 2017
1.4 years
November 19, 2015
April 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
PTSD Severity
The PTSD Checklist-Specific measures PTSD severity with 17 items rated on a 1-5 scale. Higher numbers indicate greater symptom severity.
12 weeks
Percentage of binge drinking days
The Timeline Follow-back measures will record daily alcohol consumption.
12 weeks
Study Arms (2)
Peer-Supported Web CBT
EXPERIMENTALSemi-structured brief sessions conducted weekly for the 12 weeks of study treatment by a certified peer support specialist. Sessions focus on helping participants use the skills they are learning in the Web CBT treatment in their daily lives. Web CBT consists of 24 brief (i.e., 20-minute) modules. Participants will be asked to complete two modules per week. Module topics include The Connection Between PTSD and Substance Use, Motivational Enhancement, Relaxation, Identifying, Evaluating and Challenging Automatic Thoughts, Functional Analyses of Substance Use, Substance Use Refusal Skills, Communication, Anger Management, Pain Management, and Insomnia.
Self-Managed Web CBT
EXPERIMENTALSelf-managed Web CBT consists of 24 brief (i.e., 20-minute) modules. Participants will be asked to complete two modules per week. Module topics include The Connection Between PTSD and Substance Use, Motivational Enhancement, Relaxation, Identifying, Evaluating and Challenging Automatic Thoughts, Functional Analyses of Substance Use, Substance Use Refusal Skills, Communication, Anger Management, Pain Management, and Insomnia.
Interventions
Eligibility Criteria
You may qualify if:
- At least 18 years of age,
- An OEF or OIF or OND veteran (verified via CPRS),
- Hazardous or harmful substance use as measured by one of the following: a) AUDIT score of \>=7 (for women) or \>= 8 (for men), b) DAST score of \>=2, c) Have exited a controlled environment (e.g., detoxification unit, hospital, or correctional facility) within 30 days of screening AND within 30 days prior to entering the controlled environment report heavy drinking (\>3 drinks for women or \> 4 drinks for men on 1 or more days) or use of any illegal drugs or misuse of prescription drugs (use in excess of the directions or any non-medical use), 4) Determined to have diagnostic-level PTSD (1 A symptom, 1 B symptom, 3 C symptoms AND 2 D symptoms) or subthreshold PTSD (1 A symptom, 1 B symptom, 3 C symptoms OR 2 D symptoms) on the Clinician Administered PTSD Scale (CAPS),
- \) Currently receiving primary medical care at the Syracuse VA Medical Center (verified via CPRS)
You may not qualify if:
- Plans to move out of the area within the next three months,
- Enrolled in psychotherapy in the last two months focused on substance use or PTSD,
- Have incurred a change in dose or type of a psychiatric medication that treats PTSD or substance use in the last two months,
- Inability to understand or provide informed consent,
- Inability to use English to participate in the consent process, the computerized intervention, or the assessments,
- In need of alcohol detoxification as determined by a score of \> 15 on the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar),
- Current plan or intent to harm self,
- Medical chart diagnosis of a current psychotic disorder, including schizophrenia or bi-polar disorder,
- Cognitive impairment specified by a medical chart diagnosis. Diagnoses include dementia and moderate to severe traumatic brain injury (TBI). Patients with mild TBI were not excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Syracuse Veterans Affairs Medical Center
Syracuse, New York, 13210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyle Possemato, Ph.D.
Syracuse Veterans Affairs Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Director for Research, Center for Integrated Healthcare
Study Record Dates
First Submitted
November 19, 2015
First Posted
November 23, 2015
Study Start
November 1, 2015
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
April 25, 2017
Record last verified: 2017-04